Form 4 for USPH U S PHYSICAL THERAPY INC /NV
Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-08 · accession 0000950170-24-125737 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-12 | 2024-11-08 | USPH | Trier Clayton | Dir | S - Sale | $95.78 | -2,000 | 6,424 | -24% | -$191.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-08 | S | D | 2,000 | $95.78 | 6,424 | D | — | — | (F1) The price reported ($95.78) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $95.15 to $96.84 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. (F2) Includes 712 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as 356 share in each of January 1, 2025 and April 1, 2025, if he is a director of the Company on those dates. |